COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
about
Lung cancer screeningLung cancer: epidemiology, etiology, and preventionImpact of COPD and emphysema on survival of patients with lung cancer: A meta-analysis of observational studiesComorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and ManagementThe Human Cathelicidin Antimicrobial Peptide LL-37 and Mimics are Potential Anticancer DrugsLung cancer chemoprevention: current status and future prospectsManaging comorbidities in COPDPersonalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis.Do inhaled corticosteroids protect against lung cancer in patients with COPD? A systematic reviewComputed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trialLung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repositoryCombining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancerPrevious lung diseases and lung cancer risk: a pooled analysis from the International Lung Cancer ConsortiumEpidemiology and management of common pulmonary diseases in older personsIndividual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPDInflammation-associated extracellular β-glucuronidase alters cellular responses to the chemical carcinogen benzo[a]pyreneLung cancer and chronic obstructive pulmonary disease: From a clinical perspectiveEliciting symptoms interpreted as normal by patients with early-stage lung cancer: could GP elicitation of normalised symptoms reduce delay in diagnosis? Cross-sectional interview study.Long acting β2-adrenocepter agonists are not associated with atrial arrhythmias after pulmonary resectionChronic obstructive pulmonary disease: effects beyond the lungs.Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary diseaseIntegrative analysis of genomic sequencing data reveals higher prevalence of LRP1B mutations in lung adenocarcinoma patients with COPDA pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancerInhaled corticosteroids have a protective effect against lung cancer in female patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study.Retinoic acid-related orphan receptor-α is induced in the setting of DNA damage and promotes pulmonary emphysema.Pulmonary emphysema is a risk factor for radiation pneumonitis in NSCLC patients with squamous cell carcinoma after thoracic radiation therapyGenetic test to stop smoking (GeTSS) trial protocol: randomised controlled trial of a genetic test (Respiragene) and Auckland formula to assess lung cancer riskLobar lung resection in elderly patients with non-small cell lung carcinoma: impact of chronic obstructive pulmonary disease on surgical outcome.Epidemiology and clinical impact of major comorbidities in patients with COPD.COPD is frequent in conditions of comorbidity in patients treated with various diseases in a university hospital.Impact of COPD in patients with lung cancer and advanced disease treated with chemotherapy and/or tyrosine kinase inhibitors.Is previous respiratory disease a risk factor for lung cancer?Association between chronic obstructive pulmonary disease and lung cancer: a case-control study in Southern Chinese and a meta-analysisMethod for evaluating multiple mediators: mediating effects of smoking and COPD on the association between the CHRNA5-A3 variant and lung cancer riskHigher risk of wheeze in female than male smokers. Results from the Swedish GA 2 LEN study.Diagnosis and early detection of COPD using spirometryUpdate on the potential role of statins in chronic obstructive pulmonary disease and its co-morbidities.Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease and subsequent overall and lung cancer mortality in low-income adults.The Frequency of Epidermal Growth Factor Receptor Mutation of Nonsmall Cell Lung Cancer according to the Underlying Pulmonary Diseases
P2860
Q24600430-7BCB5F6F-0678-495F-9416-37E83D55BB87Q24630167-1C86A0B9-03F3-45B0-9AC0-702586C4CFFDQ26777142-7769E6AB-4DF3-4289-A3D3-A3E90162D486Q26799659-E568CDDC-9C26-4E8F-8B24-5B0F0CB3CBCFQ26801532-9D0E3ECE-90B9-4C61-B8E5-36AA5ADF7867Q26995495-B79FEDA5-3CE6-4052-A4B6-4B75AF1DF930Q27005858-E41E8218-D8AE-4576-86D2-80817888974DQ27336183-AA12A6FD-BBC9-4505-B607-5E6EB93EAA63Q28069762-953EC3E4-9BDD-4DF4-8858-F73073FB3F7EQ28285393-EB7C4D68-45FC-478E-97BE-6F7A6BE02B19Q28384727-72B02DEA-D8A2-4857-8C8D-22A25523AF96Q28388778-9E2D59DC-0109-46C9-842F-CC7E0D39077EQ28392363-12D54E21-D3B7-40A7-AEF6-52B441A64CCEQ28397465-AF105E1A-FDE0-4955-AA82-E1014D454888Q28743099-0ED1C5BC-3F4A-43AA-82D9-26D8393BC6B9Q28830448-1DD9ACFD-8153-407F-9B82-F7FFEB2FB2BCQ30239798-08D028FB-FDC2-4372-AAA2-DE20E43CAF90Q30530822-AD613BA1-EEAA-49F8-B774-092322B9AF9CQ30851904-4F9DAF1C-6584-4BA9-A93B-968ACCA59827Q33543733-93D9C13C-E1DB-48D2-9A7A-3156CA5A17BDQ33558881-3353C7C4-1B13-4B17-A2AE-9005A9595A41Q33704760-118EF69E-A4E9-4738-8156-32E5E88336AEQ33727785-740F4A12-A5E0-4C0D-B875-BB7EB893CB1DQ33728108-234954CC-5F3C-4C56-ADC4-BAF43908A43FQ33745630-CC36DBBA-2DC0-4EC2-9DF7-76EAB0189ACAQ33765949-D4E5715D-D2B7-43D9-846F-DA2B648AECDEQ33938733-A25A7F03-0872-480A-A926-F59E0A800676Q33966259-B5A33D9B-833B-44D7-ACE0-C9B023FB5EC3Q34134841-B2218737-31D0-4BF9-AA8E-0367835A36B0Q34231327-3FBDCB9B-DC45-463F-86DA-E02F5E703B39Q34355113-2DCE44B6-41A5-4292-BFF0-EB9359E3C9DEQ34425781-DAC79E8C-F1EA-4419-B607-61C1D78CFA0DQ34430876-1DB536AA-C599-4C14-960A-D90FB44D92BEQ34451044-D889AD8B-F948-4475-8FA7-5B55BA6741C2Q34565841-E82CEF4B-45A5-459C-9D9D-8B14A456620FQ34628631-9EDAE0B4-02C4-48D2-897E-B628DAFE6294Q34656726-2BC4799F-D3CE-4A2A-AFD0-CC49E5702E13Q34899176-EB5494BA-6592-437F-B3FE-7B4E7642954AQ35219984-FEF78F5C-A3F7-4114-A004-5CFFF8996721Q35608617-BA21DFBA-F784-47D8-8FE0-2968BA62B717
P2860
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
@ast
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
@en
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
@nl
COPDの有病率は、年齢、性別、喫煙歴に関係なく、肺癌において増加している
@ja
type
label
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
@ast
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
@en
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
@nl
COPDの有病率は、年齢、性別、喫煙歴に関係なく、肺癌において増加している
@ja
prefLabel
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
@ast
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
@en
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
@nl
COPDの有病率は、年齢、性別、喫煙歴に関係なく、肺癌において増加している
@ja
P2093
P1476
COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
@en
P2093
G D Gamble
R J Hopkins
T Christmas
P304
P356
10.1183/09031936.00144208
P577
2009-02-05T00:00:00Z